FDx Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

FDx Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-14,240	Closed	-$287K	–	1171
2018 Q1	$287K	Sell	14,240 -10,447	-42%	-$244K	0.01%	984
2017 Q4	$495K	Buy	24,687 +838	+4%	+$16.5K	0.01%	809
2017 Q3	$494K	Sell	23,849 -268	-1%	-$4.53K	0.01%	813
2017 Q2	$357K	Buy	24,117 +3,033	+14%	+$50.5K	0.01%	922
2017 Q1	$336K	Buy	21,084 +1,728	+9%	+$24.9K	0.01%	942
2016 Q4	$244K	Buy	+19,356	New	+$361K	0.01%	1015

Other funds holding DPLO

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

FDx Advisors's DPLO Position: Q2 2018 in Review

FDx Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 14,240 shares — an estimated $287K sold.

FDx Advisors first reported a position in DPLO in Q4 2016 and held it in 6 quarters. The position peaked at $495K in Q4 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

FDx Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
FDx Advisors sold 14,240 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $287K.
FDx Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 6 quarters.
FDx Advisors's DIPLOMAT PHARMACY, INC. position peaked at $495K in Q4 2017.
206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on FDx Advisors's 13F filing for Q2 2018, filed 8 Aug 2018.